VAXON BIOTECH

3 RUE DE L ARRIVEE
75015, Paris 15e Arrondissement  France
+33-142184550
Company Type: Public Limited Company Parent

Vaxon Biotech is a biopharmaceutical company focused on the treatment of cancers and related malignancies. Disease targets include breast, lung, pancreatic, and prostate cancer. The company's claim to fame is its development of optimized cryptic peptide antigens (substances that trigger protein responses in the immune system), which have shown early progress in the immune response against these cancers. The company's development products are classified as therapeutic vaccines and are developed to trigger the immune system to attack malignant cells in solid tumors while steering clear from normal cells. The Paris-based, private company was founded in 2004.

Try D&B Hoovers Free

Financial Statements

Revenue in USD

Annual Revenue 2015
$2.15 million USD
1 USD = 0.931 EUR

Dun & Bradstreet collects private company financials for more than 23 million companies in over 200 countries. Find out more.

Competitor Profiles

See detailed profiles for insights and prospects on this company's top competitors.

Company Snapshot

Essential information for a successful call

  •  EMPLOYEES (This Site) 3
  •  REVENUE (MIL USD) 2.15
  • Incorporated 2004
  • FISCAL YEAR END DEC

Get in Touch with 5 Principals*

A D&B Hoovers Subscription is your foot in the door to VAXON BIOTECH contact information.
  • Jean-Pierre KINET
    Chairman of the Board
  • Kostantinos KOSMATOPOULOS
    General Manager and Board Member
  • Herve Jacques Ino Francois ARDITTY
    Chief Representative
  • Bénédicte ICHE
    Board Member
See full contact details
Start Your Free Trial

Get full access to D&B Hoovers

With a Hoovers subscription you can get a comprehensive view of VAXON BIOTECH

VAXON BIOTECH*

5
Principals
See who the company's key decision makers are
3
Corporate Relations
Get the big picture on a company's affiliates and who they do business with.
9
Close Industry Peers
See similar companies for insight and prospecting.
*Contacts and Principals counts are estimates and may differ from the actual number of contacts available in D&B Hoovers.